Dimethyldithiocarbamate zinc salt
Common Name: |
Dimethyldithiocarbamate zinc salt |
IUPAC Name: |
zinc;N,N-dimethylcarbamodithioate |
Molecular Formula: |
C6H12N2S4Zn |
SMILES: |
CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Zn+2] |
Inchi: |
1S/2C3H7NS2.Zn/c2*1-4(2)3(5)6;/h2*1-2H3,(H,5,6);/q;;+2/p-2 |
Inchi Key: |
DUBNHZYBDBBJHD-UHFFFAOYSA-L |
Cas No: |
137-30-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
1 |
Egan Violations |
1 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
316.55 |
Mass (g/mol) |
303.917 |
Molar Refractivity |
60.92 |
Net Charge |
|
HBD |
4 |
HBA |
10 |
Rt Bonds |
8 |
Rings |
|
TPSA |
206.90 |
Hetero Atoms |
|
Heavy Atoms |
21 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
|
iLOGP |
-63.66 |
XLOGP3 |
-7.20 |
WLOGP |
-4.14 |
MLOGP |
-6.22 |
ESOL Log S |
3.26 |
ESOL Solubility (mg/ml) |
578000 |
ESOL Solubility (mol/l) |
1830 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
3.58 |
Ali Solubility (mg/ml) |
1190000 |
Ali Solubility (mol/l) |
3760 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
0.89 |
Silicos-IT Solubility (mg/ml) |
2480 |
Silicos-IT Solubility (mol/l) |
7.83 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-13.34 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.222 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.504 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |